China Heavy Ion Cancer Treatment Center settled in Lanzhou

China Heavy Ion Cancer Treatment Center settled in Lanzhou

On July 19, the signing ceremony of the "Lanzhou Heavy Ion Cancer Treatment Center Project", jointly constructed by the Lanzhou Municipal Government, the Institute of Modern Physics of the Chinese Academy of Sciences and Gansu Shengda Group, was held in Lanzhou. This marks the official establishment of China's first heavy ion cancer center in Lanzhou. This makes China formally enter the list of countries that can carry out large-scale heavy ion treatment of cancer after being the fourth country in the world to carry out clinical trials of heavy ion tumor treatment.

It is reported that the construction land of the treatment center will reach 200 mu, and the construction land of the related Lanzhou ion beam research device and R & D base will reach 400 mu. The total investment exceeds RMB 1 billion and the construction period does not exceed 3 years. After completion, it will be a medical unit integrating local superior medical resources, and the final treatment center will be an open heavy ion cancer treatment platform.

Zhan Wenlong, vice president of the Chinese Academy of Sciences, said that China is the fourth country in the world to carry out clinical trials of heavy ion tumor therapy. Since the 1970s, the United States, Germany, Japan, and China have begun to use heavy ion beams to treat tumors. China's cancer incidence and mortality rate is very high, with more than 2 million new cases each year and increasing year by year. The number of deaths has ranked first among various diseases. The treatment of cancer with heavy ions is recognized as an advanced and effective radiotherapy method in the contemporary era, and there has been an upsurge of building special accelerator devices for heavy ion therapy internationally. Compared with conventional radiation treatment of tumors such as electrons, X-rays and other conventional rays, heavy ion beam has proved to be the most advanced and effective radiotherapy method in the world today. For patients, it has light radiation damage to healthy tissues, short treatment period, and cure. High rate and other characteristics.

At the signing ceremony, Zhang Jinliang, vice chairman of Gansu Provincial Committee of the Chinese People's Political Consultative Conference and mayor of Lanzhou City, said that Lanzhou will give the most favorable land for the construction of heavy ion treatment bases as high-tech industries for public welfare and independent innovation and national major scientific research base facilities Land exemption policy. At the same time, the construction of the center will be given policy support as a major project.

It is reported that in recent years, the Chinese Academy of Sciences Near Institute of Physics and the Lanzhou Military Region General Hospital and Gansu Provincial Cancer Hospital and other medical units have cooperated in clinical trials to treat 9 batches of 109 patients with superficial tumors (body depth less than 2.5 cm), and on March 31 this year We successfully carried out heavy ion therapy for the first group of 6 patients with deep tumors (body depth of 2 to 10 cm). The treatment effect is remarkable, making China the fourth country in the world to achieve clinical treatment of heavy ion cancer.

The expected social and economic benefits of heavy ion therapy have also aroused great concern in society. After screening, Gansu Shengda Group, one of the top 500 private enterprises in China, officially entered the pre-construction work of the heavy ion therapy center as a full investor. Gansu Shengda Group Co., Ltd. is a local enterprise in Gansu. In 2008, it ranked 199th among the top 500 private enterprises in China.

Intelligent Mobile Disinfection Channel

Intelligent Mobile Disinfection Channel,Smart Mobile Temperature Disinfection Channel,Intelligent Mobile Temperature Measurement & Disinfection Channel,Smart Mobile Temperature Measurement and Disinfection Channel

Rejoice International, Inc. , https://www.supercleanmedical.com